Anna L. Travelstead

881 total citations
18 papers, 691 citations indexed

About

Anna L. Travelstead is a scholar working on Neurology, Genetics and Rheumatology. According to data from OpenAlex, Anna L. Travelstead has authored 18 papers receiving a total of 691 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Neurology, 7 papers in Genetics and 6 papers in Rheumatology. Recurrent topics in Anna L. Travelstead's work include Autoimmune Neurological Disorders and Treatments (14 papers), Genetics and Neurodevelopmental Disorders (7 papers) and Glycogen Storage Diseases and Myoclonus (6 papers). Anna L. Travelstead is often cited by papers focused on Autoimmune Neurological Disorders and Treatments (14 papers), Genetics and Neurodevelopmental Disorders (7 papers) and Glycogen Storage Diseases and Myoclonus (6 papers). Anna L. Travelstead collaborates with scholars based in United States, Czechia and Slovakia. Anna L. Travelstead's co-authors include Michael R. Pranzatelli, Elizabeth D. Tate, Tyler Allison, Jerry A. Colliver, Steven J. Verhulst, David Neal Franz, E. Tate, S J Verhulst, David A. Stumpf and Edward J. Moticka and has published in prestigious journals such as Neurology, PEDIATRICS and The Journal of Infectious Diseases.

In The Last Decade

Anna L. Travelstead

18 papers receiving 676 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anna L. Travelstead United States	16	500	177	143	127	84	18	691
Adrian Budhram Canada	15	755 1.5×	162 0.9×	84 0.6×	33 0.3×	298 3.5×	85	971
Christian Probst Germany	10	239 0.5×	151 0.9×	83 0.6×	162 1.3×	203 2.4×	23	506
Hacer Durmuş Türkiye	15	327 0.7×	50 0.3×	72 0.5×	65 0.5×	63 0.8×	49	594
Carmen Alcalá Spain	11	481 1.0×	77 0.4×	98 0.7×	19 0.1×	252 3.0×	23	743
Leslie Benson United States	12	650 1.3×	214 1.2×	50 0.3×	19 0.1×	585 7.0×	23	964
H. Link Germany	17	179 0.4×	73 0.4×	56 0.4×	39 0.3×	139 1.7×	41	862
Gregorio Spagni Italy	14	528 1.1×	67 0.4×	40 0.3×	20 0.2×	168 2.0×	33	708
Paraskevi Zisimopoulou Greece	18	747 1.5×	49 0.3×	20 0.1×	63 0.5×	89 1.1×	36	1.1k
J. J. De Laey Belgium	22	122 0.2×	90 0.5×	87 0.6×	29 0.2×	55 0.7×	84	1.3k
C Laterre Belgium	13	278 0.6×	32 0.2×	46 0.3×	40 0.3×	52 0.6×	27	740

Countries citing papers authored by Anna L. Travelstead

Since Specialization

Citations

This map shows the geographic impact of Anna L. Travelstead's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna L. Travelstead with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna L. Travelstead more than expected).

Fields of papers citing papers by Anna L. Travelstead

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna L. Travelstead. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna L. Travelstead. The network helps show where Anna L. Travelstead may publish in the future.

Co-authorship network of co-authors of Anna L. Travelstead

This figure shows the co-authorship network connecting the top 25 collaborators of Anna L. Travelstead. A scholar is included among the top collaborators of Anna L. Travelstead based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna L. Travelstead. Anna L. Travelstead is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Pranzatelli, Michael R., Elizabeth D. Tate, Nathan R. McGee, et al.. (2013). BAFF/APRIL system in pediatric OMS: relation to severity, neuroinflammation, and immunotherapy. Journal of Neuroinflammation. 10(1). 10–10. 37 indexed citations

Pranzatelli, Michael R., E. Tate, Nathan R. McGee, et al.. (2013). Expression of CXCR3 and its ligands CXCL9, -10 and -11 in paediatric opsoclonus–myoclonus syndrome. Clinical & Experimental Immunology. 172(3). 427–436. 15 indexed citations

Pranzatelli, Michael R., Elizabeth D. Tate, Nathan R. McGee, et al.. (2012). Key role of CXCL13/CXCR5 axis for cerebrospinal fluid B cell recruitment in pediatric OMS. Journal of Neuroimmunology. 243(1-2). 81–88. 32 indexed citations

Pranzatelli, Michael R., Elizabeth D. Tate, Anna L. Travelstead, & Steven J. Verhulst. (2011). Chemokine/cytokine profiling after rituximab: Reciprocal expression of BCA-1/CXCL13 and BAFF in childhood OMS. Cytokine. 53(3). 384–389. 20 indexed citations

Pranzatelli, Michael R., Elizabeth D. Tate, Shalini Shenoy, & Anna L. Travelstead. (2011). Ofatumumab for a rituximab‐allergic child with chronic‐relapsing paraneoplastic opsoclonus–myoclonus. Pediatric Blood & Cancer. 58(6). 988–991. 19 indexed citations

Pranzatelli, Michael R., et al.. (2011). Cerebrospinal Fluid Oligoclonal Bands in Childhood Opsoclonus-Myoclonus. Pediatric Neurology. 45(1). 27–33. 22 indexed citations

Pranzatelli, Michael R., Elizabeth D. Tate, Anna L. Travelstead, et al.. (2010). B cell depletion therapy for new‐onset opsoclonus‐myoclonus. Movement Disorders. 25(2). 238–242. 40 indexed citations

Pranzatelli, Michael R., et al.. (2009). Insights on Chronic-Relapsing Opsoclonus-Myoclonus From a Pilot Study of Mycophenolate Mofetil. Journal of Child Neurology. 24(3). 316–322. 23 indexed citations

Pranzatelli, Michael R., Elizabeth D. Tate, Anna L. Travelstead, & Jerry A. Colliver. (2009). Long-Term Cerebrospinal Fluid and Blood Lymphocyte Dynamics After Rituximab for Pediatric Opsoclonus-Myoclonus. Journal of Clinical Immunology. 30(1). 106–113. 24 indexed citations

10.

Pranzatelli, Michael R., Elizabeth D. Tate, Anna L. Travelstead, et al.. (2006). Rituximab (anti-CD20) Adjunctive Therapy for Opsoclonus-Myoclonus Syndrome. Journal of Pediatric Hematology/Oncology. 28(9). 585–593. 103 indexed citations

11.

Pranzatelli, Michael R., Anna L. Travelstead, E. Tate, et al.. (2004). B- and T-cell markers in opsoclonus–myoclonus syndrome. Neurology. 62(9). 1526–1532. 125 indexed citations

12.

Pranzatelli, Michael R., Anna L. Travelstead, Elizabeth D. Tate, Tyler Allison, & Steven J. Verhulst. (2004). CSF B‐cell expansion in opsoclonus‐myoclonus syndrome: A biomarker of disease activity. Movement Disorders. 19(7). 770–777. 70 indexed citations

13.

Pranzatelli, Michael R., Anna L. Travelstead, Elizabeth D. Tate, et al.. (2004). Immunophenotype of Blood Lymphocytes in Neuroblastoma-Associated Opsoclonus-Myoclonus. Journal of Pediatric Hematology/Oncology. 26(11). 718–723. 22 indexed citations

14.

Pranzatelli, Michael R., Anna L. Travelstead, E. Tate, et al.. (2004). B- and t-cell markers in opsoclonus-myoclonus syndrome: immunophenotyping of CSF lymphocytes. American Journal of Ophthalmology. 138(2). 319–319. 7 indexed citations

15.

Pranzatelli, Michael R., Elizabeth D. Tate, Anna L. Travelstead, & Darryl C. Longee. (2004). Immunologic and Clinical Responses to Rituximab in a Child With Opsoclonus-Myoclonus Syndrome. PEDIATRICS. 115(1). e115–e119. 50 indexed citations

16.

Beswick, Ellen J., Anna L. Travelstead, & M D Cooper. (2003). Comparative Studies of Glycosaminoglycan Involvement inChlamydia pneumoniaeandC. trachomatisInvasion of Host Cells. The Journal of Infectious Diseases. 187(8). 1291–1300. 15 indexed citations

17.

Travelstead, Anna L., et al.. (2000). Evidence for an interferon-related inflammatory reaction in the trisomy 16 mouse brain leading to caspase-1-mediated neuronal apoptosis. Journal of Neuroimmunology. 110(1-2). 66–75. 26 indexed citations

18.

Herold, Betsy C., Risa Kirkpatrick, Daniel Marcellino, et al.. (1999). Bile Salts: Natural Detergents for the Prevention of Sexually Transmitted Diseases. Antimicrobial Agents and Chemotherapy. 43(4). 745–751. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact